FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between A G Universal IPO and Sotac Pharmaceuticals IPO.
A G Universal IPO is a SME Book Built Issue IPO proposed to list at NSE SME while Sotac Pharmaceuticals IPO is a SME Book Built Issue proposed to list at NSE SME.
A G Universal IPO | Sotac Pharmaceuticals IPO | |
---|---|---|
Logo | ||
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Fixed Price Issue | Book Built Issue |
Listing At | NSE SME | NSE SME |
Lead Managers | Share India Capital Services Private Limited | Beeline Capital Advisors Pvt Ltd |
Registrar | Skyline Financial Services Private Ltd | Kfin Technologies Limited |
Market Maker | Share India Securities Limited | Sunflower Broking Private Limited |
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of A G Universal IPO is up to ₹8.72 Cr whereas the issue size of the Sotac Pharmaceuticals IPO is up to ₹33.30 Cr. The final issue price of A G Universal IPO is ₹60.00 per share and of Sotac Pharmaceuticals IPO is ₹111.00 per share.
A G Universal IPO | Sotac Pharmaceuticals IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ₹105.00 per share | |
Issue Price (Upper) | ₹111.00 per share | |
Issue Price (Final) | ₹60.00 per share | ₹111.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 2000 shares | 1200 shares |
Fresh Issue Size | 14,54,000 shares | 30,00,000 shares |
Fresh Issue Size (Amount) | up to ₹8.72 Cr | up to ₹33.30 Cr |
OFS Issue Size | ||
OFS Issue Size (Amount) | ||
Issue Size Total | 14,54,000 shares | 30,00,000 shares |
Issue Size Total (Amount) | up to ₹8.72 Cr | up to ₹33.30 Cr |
A G Universal IPO opens on Apr 11, 2023, while Sotac Pharmaceuticals IPO opens on Mar 29, 2023. The closing date of A G Universal IPO and Sotac Pharmaceuticals IPO is Apr 13, 2023, and Apr 03, 2023, respectively.
A G Universal IPO | Sotac Pharmaceuticals IPO | |
---|---|---|
Anchor Bid Date | Mar 28, 2023 | |
Issue Open | Apr 11, 2023 | Mar 29, 2023 |
Issue Close | Apr 13, 2023 | Apr 03, 2023 |
Basis Of Allotment (Tentative) | Apr 19, 2023 | Apr 10, 2023 |
Initiation of Refunds (Tentative) | Apr 20, 2023 | Apr 11, 2023 |
Credit of Share (Tentative) | Apr 21, 2023 | Apr 12, 2023 |
Listing date (Tentative) | Apr 24, 2023 | Apr 13, 2023 |
Anchor Lockin End date 1 | May 19, 2023 | May 10, 2023 |
Anchor Lockin End date 2 | Jul 18, 2023 | Jul 09, 2023 |
A G Universal IPO P/E ratio is 3.12, as compared to Sotac Pharmaceuticals IPO P/E ratio of 132.14.
A G Universal IPO | Sotac Pharmaceuticals IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 95.53% | 84.63% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 70.20% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 3.12 | 132.14 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹32.90 Cr. | ₹122.66 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 39.79%% | 6.38%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 13.49%% | 19.03%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 1.41 | 2.74 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹5.07 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 16.91%% |
In the A G Universal IPO retail investors (RII) are offered 7,27,000 shares while in Sotac Pharmaceuticals IPO retail investors are offered 7,27,000 shares. Qualified institutional buyers (QIB) are offered 0 shares in A G Universal IPO and 5,71,800 shares in Sotac Pharmaceuticals IPO.
A G Universal IPO | Sotac Pharmaceuticals IPO | |
---|---|---|
Anchor Investor Reserveration | 8,53,200 shares | |
Market Maker Reserveration | 74,000 shares | 1,50,000 shares |
QIB | 0 shares | 5,71,800 shares |
NII | 7,27,000 shares | 4,28,400 shares |
RII | 7,27,000 shares | 9,98,400 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 14,54,000 shares | 19,98,600 shares |
A G Universal IPO subscribed 3.36x in total, whereas Sotac Pharmaceuticals IPO subscribed 1.60x.
A G Universal IPO | Sotac Pharmaceuticals IPO | |
---|---|---|
QIB (times) | 1.00x | |
NII (times) | 3.71x | 4.04x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 2.54x | 0.91x |
Employee (times) | ||
Other (times) | ||
Total (times) | 3.36x | 1.60x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|